AbbVie inks immune disorder drug licensing deal with China's FutureGen | WKZO

Retrieved on: 2024-06-13 15:09:43

Tags for this article:

Click the tags to see associated articles and topics

AbbVie inks immune disorder drug licensing deal with China's FutureGen | WKZO. View article details on hiswai:

Excerpt

Also, FutureGen's drug candidate, FG-M701, is a next-generation therapy in a class of monoclonal antibody ... antibodies, a target of interest for major ...

Article found on: wkzo.com

View Original Article